Clinical Trials

Clinical Trials

To join a current clinical trial or apply for future trials, click on the button to submit your contact information. You will be contacted to determine your eligibility for participation and potential to be compensated for your time and travel if you are accepted into a clinical trial. Patients who participate in clinical trials have access to the most advanced, evidence-based and cutting edge of new treatments that adhere to the highest safety standards. Interested participants do not need to live in the same state where the clinical trial is located.

Join Clinical Trials

Hidradenitis Suppurativa (HS)

Ameriderm Research clinical trial site in Ormond Beach FL is enrolling adult patients with moderate to severe Hidradenitis Suppurativa for a clinical trial investigating new oral medications.

  • Age Group: 18-75
  • Moderate to Severe HS
  • Ormond Beach, FL
  • Trial Date: September 2020 (Recruiting)

For more information ClinicalTrials.gov or here: ClinicalTrials.gov

CALL TODAY (386) 523-0768 to see if you qualify.

Join Clinical Trial

Multiple Facial Basal Cell Carcinoma

Ameriderm Research clinical trial site in Ormond Beach FL is enroll patients 18 years of age and older who have frequent new facial Basal Cell Carcinomas into a clinical trial investigating the ability of a new topical medication for the face to reduce the need for surgical treatments. This study is not for patients with Gorlin Syndrome.

Reimbursement for travel expenses may be included.

  • Age Group: 18 and older
  • Ormond Beach, FL
  • Trial Date: December 2019 (Ongoing)

For more information ClinicalTrials.gov

CALL TODAY (386) 523-0768 to see if you qualify.

Join Clinical Trial

Atopic Dermatitis
(Eczema)

Atopic Dermatitis, often is referred to as eczema. Eczema refers to multiple different inflammatory rashes. Atopic Dermatitis is a chronic relapsing itchy variant of eczema seen in patients who have, or have family members with “atopy”. Atopy often includes other allergy based disorders seen in the patient and/or relatives: asthma, hay fever, and conjunctivitis, sensitivity to foods, wool as well as other skin and systemic findings. Read More

  • Age Group: 12 to 54
  • Ormond Beach, FL
  • Trial Date: September 2020

This trial is for patients aged 12 to 54 with moderate to severe atopic dermatitis. It involves administering injected medication co-administered with vaccination to tetanus and to meningitis. This is as a double-blind, randomized, placebo treatments controlled for 16 weeks with an 8 week follow up.

For more information ClinicalTrials.gov

CALL TODAY (386) 523-0768 to see if you qualify.

Join Clinical Trial

Prurigo Nodularis

  • Age Group: 18 and Older
  • Ormond Beach, FL
  • Trial Date: 2020 (Recruiting)

This trial is for patients aged 18 and older with moderate to severe prurigo nodularis clinically diagnoses for over 6 months. It involves administering injected medication. This is as a double-blind, randomized, placebo treatments controlled for 16 weeks with an 8 week follow up. A possible long term extension may follow the initial trial.

For more information ClinicalTrials.gov

CALL TODAY (386) 523-0768 to see if you qualify.

Join Clinical Trial

Alopecia Areata

  • Age Group: 18 to 70
  • Ormond Beach, FL
  • Trial Date: 2020 (Recruiting)

This trial is for patients aged 12 to 70 with alopecia areata. This is as a double-blind, randomized, placebo treatments controlled study of an oral medication given for 24 weeks with a 28-week open label then 4 week follow-up visit.

For more information ClinicalTrials.gov

CALL TODAY (386) 523-0768 to see if you qualify.

Join Clinical Trial

Vitiligo

Ameriderm Research continues its recruitment for a clinical trial for patients aged 12-17 with vitiligo. The study involves testing a new topical medication.

  • Age Group: 12-17
  • Ormond Beach, FL
  • Trial Date: December 2019 (Not Recruiting)

For more information ClinicalTrials.gov

Atopic Dermatitis
(Eczema)

Atopic Dermatitis, often is referred to as eczema. Eczema refers to multiple different inflammatory rashes. Atopic Dermatitis is a chronic relapsing itchy variant of eczema seen in patients who have, or have family members with “atopy”. Atopy often includes other allergy based disorders seen in the patient and/or relatives: asthma, hay fever, and conjunctivitis, sensitivity to foods, wool as well as other skin and systemic findings. Read more

  • Age Group: 12 to 17
  • Ormond Beach, FL
  • Trial Date: 2020 (Ongoing)

This trial is for patients aged 12 to 17 with moderate to severe atopic dermatitis. It involves administering oral medication co-administered with topical therapy as a double-blind, randomized, placebo treatments controlled for 52 weeks with possible extension up to 136 weeks of treatment.

For more information ClinicalTrials.gov

Acne Scarring

Acne, or acne vulgaris (common) is an inflammatory process with affects tiny hair follicles on the face, chest, back and shoulders affecting over 90 % of teenagers. It is associated with papules (red bumps), pustules, open comedones (black heads) and closed Read Morecomedones (tiny white firm papules). Acne usually resolves during the mid-twenties. In some individuals acne may persist into senior years. Factors proposed to be associated with the severity of and persistence of acne include: tobacco, sun, diets high in cholesterol, use of skin and hair products that promote acne (comedogenic products) and abrasive skin care. Treatment response varies among acne patients; new treatments are under development for those who fail to respond to current treatment. Many patients with acne can develop scarring. This may be associated with trauma to the lesions; but equally occurs spontaneously from the acne process on its own. Treatments for acne scarring are under development. https://www.dermnetnz.org/topics/acne ; https://www.aad.org/public/diseases/acne-and-rosacea/acne ; https://www.aad.org/public/diseases/acne-and-rosacea/acne-scars#treatment; https://acneandrosacea.org/

  • Age Group: 22 and Older
  • Port Orange, FL
  • Trial Date: December 2018

This trial evaluates radiofrequency for the treatment and reduction of acne scarring in patients aged 22 years and older

For more information ClinicalTrials.gov